ArticleJournal of anaesthesiology, clinical pharmacology
Impact of bispectral index monitoring on dose requirement of dexmedetomidine during total parotidectomy under general anesthesia without muscle relaxants.
Article in Journal of anaesthesiology, clinical pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: For facial nerve monitoring during parotidectomy, neuromuscular blockers should be avoided. Assessment of depth of anesthesia based on clinical signs or end-tidal anesthetic gas concentration is unreliable. We compared intraoperative dexmedetomidine requirement with and without bispectral index (BIS) monitoring in patients undergoing total parotidectomy under general anesthesia (GA) without muscle relaxants. Material and Methods: This was a prospective, randomized study conducted in 60 patients undergoing total parotidectomy under GA with nerve conduction studies. Following induction and intubation, all patients received dexmedetomidine 1 µg/kg bolus. In Group A, BIS values were continuously monitored. Following initial bolus, only when the BIS value was >50, dexmedetomidine infusion was restarted at 0.5 µg/kg/h and adjusted to maintain BIS between 40 and 50. In Group B, dexmedetomidine 1 µg/kg bolus was given, followed by 0.5 µg/kg/h initially and infusion. Infusion rate was titrated based on hemodynamic variables and patient immobility. If patients in any group moved intraoperatively, propofol 0.5 mg/kg, not >30 mg, was given, and dose of dexmedetomidine infusion was increased by 0.1 µg/kg/h increments to a maximum dose of 0.7 µg/kg/h. Results: Rate of dexmedetomidine infusion was significantly lower in Group A compared to Group B (0.058 ± 0.011 vs. 0.547 ± 0.133 µg/kg/h). Extubation time was significantly lower in Group A (14.40 ± 8.845 vs. 30.27 ± 9.903 min). Hemodynamic responses, sevoflurane and propofol consumption, incidence of intraoperative patient immobility, hypotension, and use of vasopressors were comparable in both groups. Conclusions: Use of BIS monitoring in patients undergoing total parotidectomy under GA without muscle relaxants resulted in significant reduction in intraoperative dexmedetomidine consumption with significantly shorter extubation time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.